NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

4912. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: final policy recommendations

4914. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

4917. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

4918. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

4919. Tezepelumab for severe asthma: final report

4920. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report